Overview

Gender

male

Anders Martin-Löf was appointed CFO in 2018 and is responsible for Finance, HR, IT & Administration. He is also the Deputy CEO of Oncopeptides AB since 2020.



Anders was previously CFO of Wilson Therapeutics AB and RaySearch Laboratories AB, both listed on Nasdaq Stockholm. He held various business development positions for Swedish Orphan Biovitrum where he also served as Director of Investor Relations. In addition, he has worked as a management consultant at the Boston Consulting Group, Cell Network and as co-founder and CEO of ScienceCap.